What are the major opportunities in the Natural Killer NK Cell Therapeutics market? What are the strategies for the Natural Killer NK Cell Therapeutics market?

For detailed insights on the major opportunities and strategies in the Natural Killer NK Cell Therapeutics market, Read More

How does the Natural Killer NK Cell Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Natural Killer NK Cell Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Natural Killer NK Cell Therapeutics market growth? SWOT analysis of the Natural Killer NK Cell Therapeutics market.

For detailed insights on the key dynamics influencing the Natural Killer NK Cell Therapeutics market growth and SWOT analysis of the Natural Killer NK Cell Therapeutics industry, Read More

Natural Killer (NK) Cell Therapeutics Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Natural Killer (NK) Cell Therapeutics Market Report 2026

Name: Natural Killer (NK) Cell Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Therapeutics (Natural Killer (NK) Cell Directed Antibodies, Natural Killer (NK) Cell Therapies), By Application (Immunoproliferative Disorders, Gastrointestinal Diseases, Cancer, Other Applications), By Distribution Channel (Hospital Pharmacies, Direct Tender, Other Distribution Channels), By End User (Research And Academic Institutes, Hospitals, Specialty Clinics) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Natural Killer (NK) Cell Therapeutics Market Overview

• Natural Killer (NK) Cell Therapeutics market size has reached to $3.93 billion in 2025

• Expected to grow to $6.9 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%

• Growth Driver: Rising Cancer Prevalence Fueling The Growth Due To Increasing Demand For Targeted Immunotherapies

• Market Trend: Advancements In Scalable iPSC-Based Manufacturing For Off-The-Shelf NK Cell Therapies

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Natural Killer (NK) Cell Therapeutics Market?

Natural Killer (NK) cell therapeutics are treatments that harness or enhance NK cells, a type of immune cell, to target and destroy cancer cells, infected cells, or other diseased cells. These therapies include NK cell infusions (autologous/allogeneic), CAR-NK cells (genetically modified to target specific proteins), and NK-directed antibodies (bispecific antibodies).

The main therapeutics of natural killer (nk) cell therapeutics are NK cell-directed antibodies and NK cell-based therapies. NK cell-directed antibodies are engineered to boost the ability of NK cells to recognize and eliminate cancer cells by targeting tumor-specific antigens. These therapies are applied for various applications such as cancer, immunoproliferative disorders, gastrointestinal diseases, and others. Distribution channels include hospital pharmacies, direct tenders, and others, while end-users primarily consist of hospitals, specialty clinics, and research and academic institutes.

Natural Killer (NK) Cell Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Natural Killer (NK) Cell Therapeutics Market Size and Share 2026?

The natural killer (nk) cell therapeutics market size has grown rapidly in recent years. It will grow from $3.93 billion in 2025 to $4.4 billion in 2026 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to limitations of traditional cancer therapies, advancements in immunology research, success of early nk cell therapies, growth of cell therapy infrastructure, increased oncology research funding.

What Is The Natural Killer (NK) Cell Therapeutics Market Growth Forecast?

The natural killer (nk) cell therapeutics market size is expected to see rapid growth in the next few years. It will grow to $6.9 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to expansion of cell and gene therapy pipelines, increasing demand for safer immunotherapies, advancements in cell engineering technologies, rising investment in oncology biologics, growing acceptance of allogeneic cell therapies. Major trends in the forecast period include rapid development of car-nk cell therapies, increasing use of allogeneic nk cell treatments, growing focus on off-the-shelf cell therapies, expansion of nk cell applications in oncology, rising clinical trials for nk-directed antibodies.

Book your 30 minutes free consultation with our research experts

Global Natural Killer (NK) Cell Therapeutics Market Segmentation

1) By Therapeutics: Natural Killer (NK) Cell Directed Antibodies, Natural Killer (NK) Cell Therapies

2) By Application: Immunoproliferative Disorders, Gastrointestinal Diseases, Cancer, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Direct Tender, Other Distribution Channels

4) By End User: Research And Academic Institutes, Hospitals, Specialty Clinics

Subsegments:

1) By Natural Killer (NK) Cell Directed Antibodies: Monoclonal Antibodies (mAbs), Bispecific Antibodies (BsAbs), Antibody-Drug Conjugates (ADCs)

2) By Natural Killer (NK) Cell Therapies: Autologous NK Cell Therapies, Allogeneic NK Cell Therapies, Chimeric Antigen Receptor (CAR)-NK Cell Therapies

What Is The Driver Of The Natural Killer (NK) Cell Therapeutics Market?

The rising prevalence of cancer are expected to propel the growth of the natural killer (NK) cell therapeutics market going forward. Cancer refers to diseases where abnormal cells grow uncontrollably, invade nearby tissues, and spread to other body parts. It disrupts normal cell regulation, forming tumors and impairing bodily functions. Environmental exposures to pollutants, tobacco smoke, and chemicals can damage deoxyribonucleic acid (DNA) and disrupt cellular function, increasing cancer risk. Natural killer (NK) cell therapeutics help treat cancer by directly targeting and destroying tumor cells without prior sensitization. For instance, in April 2024, according to American Cancer Society, a US-based non-profit organization, by 2050, the number of cancer cases is predicted to increase to 35 million based solely on projected population growth. Therefore, the rising prevalence of cancer is driving the growth of natural killer (NK) cell therapeutics industry.

Key Players In The Global Natural Killer (NK) Cell Therapeutics Market

Major companies operating in the natural killer (nk) cell therapeutics market are Sanofi S.A., Thermo Fisher Scientific, Lonza AG, Catalent, Kite Pharma, Fate Therapeutics, Artiva Biotherapeutics, Nkarta Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeutics, Wugen Inc., AGC Biologics, CytoImmune Therapeutics, XNK Therapeutics, Indapta Therapeutics, Neukio Biotherapeutics, Senti Biosciences, WuXi Advanced Therapies, Kiadis Pharma

Global Natural Killer (NK) Cell Therapeutics Market Trends and Insights

Major companies operating in the natural killer (NK) cell therapeutics market are focusing on advancements such as developing scalable iPSC-based NK cell manufacturing platforms, to enable cost-effective, off-the-shelf NK cell therapies. These platforms utilize induced pluripotent stem cells (iPSCs) to generate NK cells in a standardized, feeder-free, and closed-system bioreactor environment, ensuring high yields and regulatory compliance. For instance, in April 2025, Cellistic, a Belgium-based biotechnology research company, launched the Echo-NK platform, an iPSC-based manufacturing solution for NK cell therapies. The platform offers scalable production of NK cells targeting blood cancers, solid tumors, and autoimmune diseases, with all critical expansion steps performed in bioreactor closed systems within Cellistic's EMA-certified GMP facility. By integrating Cellistic's Pulse cell line development capabilities and proprietary STAR-CRISPR technology, the Echo-NK platform accelerates timelines for developing stable iPSC cell lines with specific gene edits, providing a commercially viable solution for off-the-shelf NK cell therapies.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Natural Killer (NK) Cell Therapeutics Market?

In March 2025, AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company, acquired EsoBiotec for up to $1 billion, with an initial payment of $425 million and up to $575 million in milestone-based contingent payments. AstraZeneca aims to leverage EsoBiotec’s platform to make cell therapies more accessible, scalable, and affordable for cancer patients globally, marking a significant step in expanding its cell therapy portfolio. EsoBiotec is a Belgian-based biotech company operating in cell therapeutics development.

Regional Insights

North America was the largest region in the natural killer (NK) cell therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Natural Killer (NK) Cell Therapeutics Market?

The natural killer (NK) cell therapeutics market includes revenues earned by entities by providing services such as scell therapy development, clinical trial support, contract manufacturing, regulatory consulting, and cell line engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. The natural killer (NK) cell therapeutics market also includessales of cytokine-activated NK cells, CAR-NK cell therapies, cell expansion kits, reagents, and culture media. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Natural Killer (NK) Cell Therapeutics Market Report 2026?

The natural killer (nk) cell therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the natural killer (nk) cell therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Natural Killer (NK) Cell Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.4 billion
Revenue Forecast In 2035	$6.9 billion
Growth Rate	CAGR of 12.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Therapeutics, Application, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Sanofi S.A., Thermo Fisher Scientific, Lonza AG, Catalent, Kite Pharma, Fate Therapeutics, Artiva Biotherapeutics, Nkarta Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeu
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Natural Killer (NK) Cell Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Natural Killer (NK) Cell Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Natural Killer (NK) Cell Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Natural Killer (NK) Cell Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rapid Development Of Car-Nk Cell Therapies

4.2.2 Increasing Use Of Allogeneic Nk Cell Treatments

4.2.3 Growing Focus On Off-The-Shelf Cell Therapies

4.2.4 Expansion Of Nk Cell Applications In Oncology

4.2.5 Rising Clinical Trials For Nk-Directed Antibodies

5. Natural Killer (NK) Cell Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Specialty Clinics

5.3 Research And Academic Institutes

5.4 Cell Therapy Centers

5.5 Biopharmaceutical Companies

6. Natural Killer (NK) Cell Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Natural Killer (NK) Cell Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Natural Killer (NK) Cell Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Natural Killer (NK) Cell Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Natural Killer (NK) Cell Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Natural Killer (NK) Cell Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Natural Killer (NK) Cell Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Natural Killer (NK) Cell Therapeutics Market Segmentation

9.1. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Natural Killer (NK) Cell Directed Antibodies, Natural Killer (NK) Cell Therapies

9.2. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoproliferative Disorders, Gastrointestinal Diseases, Cancer, Other Applications

9.3. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Direct Tender, Other Distribution Channels

9.4. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Research And Academic Institutes, Hospitals, Specialty Clinics

9.5. Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Directed Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies (mAbs), Bispecific Antibodies (BsAbs), Antibody-Drug Conjugates (ADCs)

9.6. Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autologous NK Cell Therapies, Allogeneic NK Cell Therapies, Chimeric Antigen Receptor (CAR)-NK Cell Therapies

10. Natural Killer (NK) Cell Therapeutics Market Regional And Country Analysis

10.1. Global Natural Killer (NK) Cell Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Natural Killer (NK) Cell Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market

11.1. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Natural Killer (NK) Cell Therapeutics Market

12.1. China Natural Killer (NK) Cell Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Natural Killer (NK) Cell Therapeutics Market

13.1. India Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Natural Killer (NK) Cell Therapeutics Market

14.1. Japan Natural Killer (NK) Cell Therapeutics Market Overview

14.2. Japan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Natural Killer (NK) Cell Therapeutics Market

15.1. Australia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Natural Killer (NK) Cell Therapeutics Market

16.1. Indonesia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Natural Killer (NK) Cell Therapeutics Market

17.1. South Korea Natural Killer (NK) Cell Therapeutics Market Overview

17.2. South Korea Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Natural Killer (NK) Cell Therapeutics Market

18.1. Taiwan Natural Killer (NK) Cell Therapeutics Market Overview

18.2. Taiwan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Natural Killer (NK) Cell Therapeutics Market

19.1. South East Asia Natural Killer (NK) Cell Therapeutics Market Overview

19.2. South East Asia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Natural Killer (NK) Cell Therapeutics Market

20.1. Western Europe Natural Killer (NK) Cell Therapeutics Market Overview

20.2. Western Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Natural Killer (NK) Cell Therapeutics Market

21.1. UK Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Natural Killer (NK) Cell Therapeutics Market

22.1. Germany Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Natural Killer (NK) Cell Therapeutics Market

23.1. France Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Natural Killer (NK) Cell Therapeutics Market

24.1. Italy Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Natural Killer (NK) Cell Therapeutics Market

25.1. Spain Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Natural Killer (NK) Cell Therapeutics Market

26.1. Eastern Europe Natural Killer (NK) Cell Therapeutics Market Overview

26.2. Eastern Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Natural Killer (NK) Cell Therapeutics Market

27.1. Russia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Natural Killer (NK) Cell Therapeutics Market

28.1. North America Natural Killer (NK) Cell Therapeutics Market Overview

28.2. North America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Natural Killer (NK) Cell Therapeutics Market

29.1. USA Natural Killer (NK) Cell Therapeutics Market Overview

29.2. USA Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Natural Killer (NK) Cell Therapeutics Market

30.1. Canada Natural Killer (NK) Cell Therapeutics Market Overview

30.2. Canada Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Natural Killer (NK) Cell Therapeutics Market

31.1. South America Natural Killer (NK) Cell Therapeutics Market Overview

31.2. South America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Natural Killer (NK) Cell Therapeutics Market

32.1. Brazil Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Natural Killer (NK) Cell Therapeutics Market

33.1. Middle East Natural Killer (NK) Cell Therapeutics Market Overview

33.2. Middle East Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Natural Killer (NK) Cell Therapeutics Market

34.1. Africa Natural Killer (NK) Cell Therapeutics Market Overview

34.2. Africa Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Natural Killer (NK) Cell Therapeutics Market Regulatory and Investment Landscape

36. Natural Killer (NK) Cell Therapeutics Market Competitive Landscape And Company Profiles

36.1. Natural Killer (NK) Cell Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Natural Killer (NK) Cell Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Natural Killer (NK) Cell Therapeutics Market Company Profiles

36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Lonza AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Catalent Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Kite Pharma Overview, Products and Services, Strategy and Financial Analysis

37. Natural Killer (NK) Cell Therapeutics Market Other Major And Innovative Companies

Fate Therapeutics, Artiva Biotherapeutics, Nkarta Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeutics, Wugen Inc., AGC Biologics, CytoImmune Therapeutics, XNK Therapeutics, Indapta Therapeutics

38. Global Natural Killer (NK) Cell Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Natural Killer (NK) Cell Therapeutics Market

40. Natural Killer (NK) Cell Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Natural Killer (NK) Cell Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Natural Killer (NK) Cell Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Natural Killer (NK) Cell Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Natural Killer (NK) Cell Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Natural Killer (NK) Cell Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Natural Killer (NK) Cell Therapeutics Market, Supply Chain Analysis

Table 4: Global Natural Killer (NK) Cell Therapeutics Market, Major Raw Material Providers

Table 5: Global Natural Killer (NK) Cell Therapeutics Market, Major Resource Providers

Table 6: Global Natural Killer (NK) Cell Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Natural Killer (NK) Cell Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Natural Killer (NK) Cell Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Natural Killer (NK) Cell Therapeutics Market, Major Trends

Table 10: Global Natural Killer (NK) Cell Therapeutics Market, Major End Users

Table 11: Global Natural Killer (NK) Cell Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Natural Killer (NK) Cell Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Natural Killer (NK) Cell Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Natural Killer (NK) Cell Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Directed Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Natural Killer (NK) Cell Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Natural Killer (NK) Cell Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Natural Killer (NK) Cell Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Natural Killer (NK) Cell Therapeutics Market - Company Scoring Matrix

Table 97: Sanofi S.A. Financial Performance

Table 98: Thermo Fisher Scientific Financial Performance

Table 99: Lonza AG Financial Performance

Table 100: Catalent Financial Performance

Table 101: Kite Pharma Financial Performance

Table 102: Global Natural Killer (NK) Cell Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Natural Killer (NK) Cell Therapeutics Market, Competitive Dashboard

Table 104: Global Natural Killer (NK) Cell Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Natural Killer (NK) Cell Therapeutics Market Size Gain ($ Billion), Segmentation By Therapeutics, 2025 – 2030

Table 106: Global, Natural Killer (NK) Cell Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 107: Global, Natural Killer (NK) Cell Therapeutics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Natural Killer (NK) Cell Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Natural Killer (NK) Cell Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Natural Killer (NK) Cell Therapeutics Market, Supply Chain Analysis

Figure 4: Global Natural Killer (NK) Cell Therapeutics Market, Major Raw Material Providers

Figure 5: Global Natural Killer (NK) Cell Therapeutics Market, Major Resource Providers

Figure 6: Global Natural Killer (NK) Cell Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Natural Killer (NK) Cell Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Natural Killer (NK) Cell Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Natural Killer (NK) Cell Therapeutics Market, Major Trends

Figure 10: Global Natural Killer (NK) Cell Therapeutics Market, Major End Users

Figure 11: Global Natural Killer (NK) Cell Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Natural Killer (NK) Cell Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Natural Killer (NK) Cell Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Natural Killer (NK) Cell Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Directed Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Natural Killer (NK) Cell Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Natural Killer (NK) Cell Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Natural Killer (NK) Cell Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Natural Killer (NK) Cell Therapeutics Market - Company Scoring Matrix

Figure 97: Sanofi S.A. Financial Performance

Figure 98: Thermo Fisher Scientific Financial Performance

Figure 99: Lonza AG Financial Performance

Figure 100: Catalent Financial Performance

Figure 101: Kite Pharma Financial Performance

Figure 102: Global Natural Killer (NK) Cell Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Natural Killer (NK) Cell Therapeutics Market, Competitive Dashboard

Figure 104: Global Natural Killer (NK) Cell Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Natural Killer (NK) Cell Therapeutics Market Size Gain ($ Billion), Segmentation By Therapeutics, 2025 – 2030

Figure 106: Global, Natural Killer (NK) Cell Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 107: Global, Natural Killer (NK) Cell Therapeutics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Cell Therapy Technologies Market Report 2026 - Global Outlook – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cell Types), By Process (Cell Processing, Cell Preservat...

Cell Regeneration Medicine Market Report 2026 - Global Outlook – By Product (Therapeutics, Tools, Banks, Services), By Therapeutic Category (Dermatology, Musculoskeletal, Immunology And Inflammation, Oncology, Cardiovasc...

Infectious Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharm...

Natural Immune Booster Market Report 2026 - Global Outlook – By Product Type (Herbal Supplements, Vitamins And Minerals, Probiotics, Functional Foods And Beverages, Essential Oils, Other Product Types), By Distribution C...

Cell Therapy Human Raw Materials Market Report 2026 - Global Outlook – By Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials), By Type Of Cell Therapy (Den...

Oncolytic Virus Therapy Market Report 2026 - Global Outlook – By Therapy Type (Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, Newcastle Disease V...

Mantle Cell Lymphoma Therapeutics Market Report 2026 - Global Outlook – By Type (Combination Therapy, Monotherapy), By Mechanism of Action (Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synt...

Frequently Asked Questions

How big is the Natural Killer (NK) Cell Therapeutics Market?

The Natural Killer (NK) Cell Therapeutics market was valued at $3.93 billion in 2025, increased to $4.4 billion in 2026, and is projected to reach $6.9 billion by 2030.

What is the Natural Killer (NK) Cell Therapeutics market growth?

The global Natural Killer (NK) Cell Therapeutics market is expected to grow at a CAGR of 11.9% from 2026 to 2035 to reach $6.9 billion by 2035.

Who are the key players in Natural Killer (NK) Cell Therapeutics market?

Some Key Players in the Natural Killer (NK) Cell Therapeutics market Include, Sanofi S.A., Thermo Fisher Scientific, Lonza AG, Catalent, Kite Pharma, Fate Therapeutics, Artiva Biotherapeutics, Nkarta Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeutics, Wugen Inc., AGC Biologics, CytoImmune Therapeutics, XNK Therapeutics, Indapta Therapeutics, Neukio Biotherapeutics, Senti Biosciences, WuXi Advanced Therapies, Kiadis Pharma .

What is the anticipated growth trend for the Natural Killer (NK) Cell Therapeutics market?

Major trend in this market includes: Advancements In Scalable iPSC-Based Manufacturing For Off-The-Shelf NK Cell Therapies. For further insights on this market. request a sample here

Which region has the most growth potential in the Natural Killer (NK) Cell Therapeutics market?

North America was the largest region in the natural killer (NK) cell therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the natural killer (nk) cell therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.